HIMS

Hims & Hers Health, Inc. (HIMS)

Monday, October 19, 2026
Past 1Y
MA21MA180
Signals
BuyEarly buySellEarly sellTurning points
Swing highSwing low
Up dayDown day

Hims & Hers Health (HIMS) at a glance

Close · Oct 19, 2026
$28.18
Day change
+0.39%
52-week range
$13.74 – $52.41
Market cap
$6.5B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE

Hims & Hers Health stock: what the data says

Hims & Hers Health (HIMS) closed at $28.18 on Oct 19, 2026, up 0.4% on the day. The stock is up 0.7% over the past month, down 13.9% over three months, down 13.2% year to date and down 52.4% over the past year. It trades 46.2% below its 52-week high of $52.41 and 105.1% above its 52-week low of $13.74. The close sits below its 50-day moving average ($29.25) and above its 200-day moving average ($27.25).

NextPick tracks HIMS in its GLP-1 / Obesity basket alongside LLY, NVO, VKTX, GPCR and ALT. As of Oct 19, 2026, the basket's money-flow score is -62 (strong outflow), and the basket is down 6.0% over five sessions. Over the past month HIMS ranks 2nd of 6 basket members by price change.

HIMS stock: key questions

Is HIMS above its 200-day moving average?

Yes — the Oct 19, 2026 close of $28.18 is 3.4% above the 200-day average of $27.25.

How far is HIMS from its 52-week high?

HIMS closed 46.2% below its 52-week high of $52.41.

What stocks are similar to HIMS?

NextPick groups HIMS with LLY, NVO, VKTX, GPCR and ALT in its GLP-1 / Obesity basket.

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

hims.com